Q3 2023

Filed Nov 3, 2023 · 10-Q · 34 days after period end · 0000950170-23-058814

Q3 2023 · 10-Q

Revenue

$750.33M

+12.5% vs Q3 2022

Net Income

-$217.71M

N/M vs Q3 2022

EPS Diluted

-$2.39

N/M vs Q3 2022

Operating Cash Flowderived$137,858,000+235.9%

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$750.33M	$666.73M	$587.56M	$547.96M
Net Income	-$217.71M	$71.10M	$66.13M	$37.00M
EPS Diluted	-$2.39	$0.78	$0.73	$0.42

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Acadia Healthcare Company, Inc. · CIK 1520697 · Engraved from SEC EDGAR